Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00620984 · ClinicalTrials.gov registry record
Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 557
- Enrollment target
NCT00620984 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 557 participants.
The verdict
NCT00620984 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 557 participants
- Enrollment target
Study Summary
Lactation (breastfeeding) mastitis is an acute infection of the milk ducts of the breastfeeding woman. Staphylococcus aureus (S. aureus) is the infectious germ most commonly associated with lactation mastitis. Twenty percent of the general population are carriers of Staphylococcus aureus, which means that they carry the infectious germ but do not become ill from it. It has been suggested that mothers who are carriers of S. aureus in their nostril may be at an increased risk of developing lactational mastitis, however; this has not been clinical proven. We are studying the relationship between S. aureus carrier status of breastfeeding mothers and infants and the risk of developing lactational mastitis. Additionally, we are collecting questionnaire data in an attempt to better define factors predisposing women to lactation mastitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 557 participants |
| Start Date | 2006-08 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00620984
The ClinicalTrials.gov registry entry for NCT00620984 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 557 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00620984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00620984 about?
NCT00620984 is a clinical study titled "Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis". Lactation (breastfeeding) mastitis is an acute infection of the milk ducts of the breastfeeding woman. Staphylococcus aureus (S. aureus) is the infectious germ most commonly associated with lactation mastitis. Twenty percent of the general population are carriers of Staphylococcus aureus, which mean...
What is the current status of trial NCT00620984?
This trial is currently completed. The enrollment target is 557 participants. The study started on 2006-08. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00620984?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.